Alzheimer-kór: vizsgálatok itt: Hollandia

In Hollandia 16 Also abroad 815

16 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.

No phaseTaking people
InRAD Observational Study
Where
Amsterdam
Életkor
18 év and over
People
50 000 worldwide
Run by
Stichting International Registry for Alzheimer's Disease and other Dementias Foundation
See details and how to joinNCT07213700
3. fázisTaking people
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Where
Amsterdam, 's-Hertogenbosch, Zwolle
Életkor
60 év to 85 év
People
586 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT06976216 · EU 2025-520746-30-00
1. fázisTaking people
A Study to Evaluate the Safety and Tolerability of ALN-APP in Patients With EOAD
Where
Amsterdam
Életkor
18 év and over
People
60 worldwide
Run by
Alnylam Pharmaceuticals
See details and how to joinNCT05231785 · EU 2023-508363-79-00
2. fázisTaking people
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
Where
Amsterdam, 's-Hertogenbosch, Zwolle
Életkor
50 év to 85 év
People
340 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07033494 · EU 2024-519190-19-00
2. fázisTaking people
A Study to Evaluate Mivelsiran in Adult Participants With Early-Stage Down Syndrome-Associated Alzheimer's Disease (DS-AD)
Where
Amsterdam
Életkor
40 év to 55 év
People
58 worldwide
Run by
Alnylam Pharmaceuticals
See details and how to joinNCT07636811 · EU 2025-523390-42-00
3. fázisTaking people
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
Where
Amsterdam, 's-Hertogenbosch, Zwolle
Életkor
60 év to 85 év
People
586 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT06976203 · EU 2025-520747-32-00
1. fázisTaking people
A Study to Evaluate ALN-5288 in Patients With Alzheimer's Disease
Where
Amsterdam, 's-Hertogenbosch
Életkor
40 év to 80 év
People
50 worldwide
Run by
Alnylam Pharmaceuticals
See details and how to joinNCT07214727 · EU 2025-522582-30-00
No phaseTaking people
Dominantly Inherited Alzheimer Network (DIAN)
Where
Amsterdam
Életkor
18 év and over
People
700 worldwide
Run by
Washington University School of Medicine
See details and how to joinNCT00869817
Korai 1. fázisTaking people
[18F]ACI-19626 PET in TDP-43 Proteinopathies
Where
Amsterdam
Életkor
40 év to 70 év
People
45
Run by
AC Immune SA
See details and how to joinNCT06891716 · EU 2024-513097-21-00
2/3. fázisTaking people
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Where
Amsterdam
Életkor
18 év and over
People
280 worldwide
Run by
Washington University School of Medicine
See details and how to joinNCT05552157
2/3. fázisTaking people
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Where
Amsterdam
Életkor
18 év and over
People
280 worldwide
Run by
Washington University School of Medicine
See details and how to joinNCT06647498
No phaseTaking people
The BRidge Towards Implementation of Blood-based Biomarkers to Enable Early and Accurate Diagnosis of Alzheimer's Disease
Where
Almere Stad, Amsterdam, Haarlem, Hilversum, Leeuwarden, Purmerend, 's-Hertogenbosch, Tilburg
Életkor
55 év and over
People
550
Run by
Alzheimercentrum Amsterdam
See details and how to joinNCT07680335
1. fázisTaking people
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL628 in Participants With Early Alzheimer's Disease
Where
Amsterdam, 's-Hertogenbosch, Zwolle
Életkor
18 év to 75 év
People
68 worldwide
Run by
Denali Therapeutics Inc.
See details and how to joinNCT07328451 · EU 2025-523515-11-00
No phaseTaking people
Transcranial Magnetic Stimulation to Slow Down Cognitive Decline in Alzheimer's Disease
Where
Amsterdam
Életkor
50 év to 85 év
People
55
Run by
Willem de Haan
See details and how to joinNCT07036328
1/2. fázisTaking people
A Phase 2a, dose-finding, randomized, double-blinded, placebo-controlled study to Evaluate the Pharmacodynamics, Pharmacokinetics, and Safety of Efavirenz in Patients with Early Alzheimer’s Disease
Where
Amsterdam
Életkor
18 év and over
People
40
Run by
Amsterdam UMC
See details and how to join2023-509613-37-01 · EU 2023-509613-37-01
2. fázisNot yet taking people in Hollandia
Evaluation of [18F]MC225 to measure P-glycoprotein function in neurodegenerative disease
Where
Groningen
Életkor
18 év and over
People
30
Run by
Universitair Medisch Centrum Groningen
See details and how to join2024-518865-85-00 · EU 2024-518865-85-00